Report Highlights
The global biopsy devices market should reach $3.1 billion by 2027 from $2.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.8% for the forecast period of 2022 to 2027.
Report Includes
- 44 data tables and 21 additional tables
- Detailed overview and an up-to-date analysis of the global market for biopsy devices
- Analyses of the global market trends, with revenue data (sales figures) for 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for the global biopsy devices market, and corresponding market share analysis by device type, therapeutic area/application, image guiding technology, end user, and region
- Identification of the viable technology drivers and barriers through a holistic review of various next generation imaging technologies used in the process of performing biopsies and their key therapeutic areas in the cancer diagnostics market
- Review of cancer statistics and epidemiology insights and SWOT analysis of various cancer biotherapeutics present in the market
- A look at major issues and trends with relate to the R&D of more effective cancer treatment, and new cancer therapeutics in development, and outlook on cancer clinical trials
- Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in manufacturing and development of biopsy devices, emerging trends and technology developments, along with the COVID-19 implications on the marketplace
- Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
- Patent grants and patent applications on biopsy devices and cancer diagnostics industry
- Descriptive company profiles of the leading market players, including Argon Medical Devices Inc., Boston Scientific Corp., FujiFilm Holdings Corp., Mammotome, and Olympus Corp.
Report Scope
This research report presents an in-depth analysis of the global market for biopsy devices, segmented by product type, imaging technique, application, end user and geographic markets. It discusses key devices (vacuum-assisted biopsy [VAB] devices, fine needle aspiration biopsy [FNAB] devices, core needle biopsy [CNB] devices, biopsy guidance systems, biopsy needles, biopsy forceps and others). Applications include trends and market estimates of key application areas (breast cancer, gastrointestinal cancer, lung cancer, liver cancer, prostate cancer and cervical cancer, among others). This report focuses on key imaging technologies used in the process of performing biopsies (ultrasound, magnetic resonance imaging [MRI], computed tomography [CT] and others). The report also reviews the supply chain from manufacturers to surgeons.
The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||
| Base year market size | $2.1 billion | ||||||||||||||||||
| Market size forecast | $3.1 billion | ||||||||||||||||||
| Growth rate | CAGR of 6.8% | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | product type, application, imaging-guiding technology, and end-user | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and ROW | ||||||||||||||||||
| Countries covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.
Report Includes
- An overview of the global biopsy devices market.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
- Segmented analyses based on devices, therapeutic segments, and geographies
- Information on key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and non–thermal ablation techniques
- Analyses of key strategies, competitive insights, and developments of key companies in the market
- Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants
- Evaluation of key and relevant patents
- Analysis of the key strategies, competitive insights and development of key companies in the market
Report Highlights
The global market for biopsy devices reached $1.4 billion in 2013. This market is further expected to grow to $1.5 billion in 2014 and $1.9 billion in 2018, a compound annual growth rate (CAGR) of 6.3% over the five year period, 2013 to 2018.
Report Includes
- An overview of the global biopsy devices market.
- Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Segmented analyses based on devices, therapeutic segments, and geographies.
- Analyses of key strategies, competitive insights, and developments of key companies in the market.
- Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants.
- Evaluation of key and relevant patents.
- Comprehensive profiles of leading companies in the industry.
Related Reports
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Next-Generation Cancer Diagnostics: Technologies and Global Markets
The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.
Medical Devices: Technologies and Global Markets
The global market for medical device technologies is valued at $639.1 billion in 2021 and is estimated to grow from $676.0 billion in 2022 to $953.4 billion in 2027 with a compound annual growth rate (CAGR)of 7.1% for the period of 2022-2027.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy should increase from $3.8 billion in 2020 to $19.6 billion by 2025, at a compound annual growth rate (CAGR) of 38.5% during the period of 2020-2025.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More